Author(s) : Chene, G , Sterne, JA , May, M , Costagliola, D , Ledergerber, B , Phillips, AN , Dabis, F , Lundgren, J , d'Arminio, MA , de Wolf, F

Description : BACKGROUND: We examined whether the initial virological and immunological response to highly active antiretroviral treatment (HAART) is prognostic in patients with HIV-1 who start HAART. METHODS: We analysed 13 cohort studies from Europe and North America including 9323 adult treatment-naive patient...

Repository : UCL Eprints , View repository documents

Language(s) : Undetermined

Subject(s) : ACCOUNT, Acquired Immunodeficiency Syndrome, adolescent, adult, AGENT, AGENTS, AIDS, analysis, Anti HIV, Anti-HIV Agents, antiretroviral, antiretroviral therapy, Antiretroviral Therapy, Highly Active, ANTIRETROVIRAL-THERAPY, CD4, CD4 CELL COUNT, CD4 Lymphocyte Count, cell, Cell Count, clinical, COHORT, Cohort Studies, cohort study, COMBINATION, Comparative Study, Concentration, DEATH, DEVELOPED, disease, Disease Progression, DRUG, drug therapy, DRUGS, epidemiology, Europe, Female, FOLLOW UP, Follow-up, Follow-Up Studies, guideline, Guidelines, HAART, HIV 1, HIV Infections, Hiv-1, IM, immunology, INFECTED PATIENTS, LA, LOAD, Male, Methods, Middle Aged, NORTH, North America, Patient, patients, POTENT, PROBABILITY, Prognosis, prognostic, PROGRESSION, Prospective Studies, prospective study, RATIO, response, Rna, starting, statistics & numerical data, SUBSEQUENT, Support, Non-U.S.Gov\'t, therapeutic use, therapy, treatment, Treatment Outcome, VALUES, viral, Viral Load, virology, analysis, collaboration, HIVE

Publisher(s) :

Contributor(s) :

Source(s) :

Publication Date(s) : 2003-08-30